Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0CPT: Pharmacometrics & Systems Pharmacology

Longitudinal Modeling of Cardiometabolic Dysfunction in Patients With Type 2 Diabetes Using Item Response Theory

  1. 1Pharmacometrics Research Group, Department of Pharmacy Uppsala University Uppsala Sweden
  2. 2Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME Paris France

Abstract

Cardiometabolic dysfunction in patients with type 2 diabetes (T2D) is reflected by multiple risk factors and cannot be fully characterized by any single biomarker. Item response theory (IRT) provides a framework for integrating observed risk factors into latent measures of underlying cardiometabolic dysfunction. Routinely collected measurements of systolic and diastolic blood pressure (sBP and dBP), high‐ and low‐density lipoproteins (HDL and LDL), triglycerides (TG), HbA1c, and BMI from 33,396 adults newly diagnosed with T2D were analyzed, with biomarkers categorized into four ordered levels. A two‐dimensional model described the data better than a unidimensional, identifying a blood pressure‐related latent variable (ψ 1) primarily informed by sBP and dBP, and a metabolic latent variable (ψ 2) primarily informed by HDL, HbA1c, TG, and BMI, while LDL showed low discrimination on both dimensions. At baseline, age at T2D diagnosis was associated with both latent variables, with opposing effects of 0.02 for ψ 1 and −0.07 for ψ 2. Sex was associated with ψ 2, with women scoring 0.43 units lower than men on the latent variable scale. Longitudinally, ψ 1 and ψ

2 showed post‐baseline offsets of −0.10 and −0.22, respectively, followed by separately estimated annual slopes of approximately −0.03 year−1. HbA1c exhibited a distinct trajectory with an initial post‐baseline improvement followed by deterioration, requiring an item‐specific slope of 0.45 year−1. The ψ 2 contributed modest additional information for all‐cause mortality beyond age and sex. This framework integrated routinely collected biomarkers into continuous latent measures of multidimensional cardiometabolic dysfunction while accounting for differences in their contributions to the latent dimensions.

Related

  1. Association of longitudinal serum 25-hydroxyvitamin D trajectories with subsequent liver stiffness increase in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease
    Hong Ji, Runzhou Pan, Xiaowei Huang
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossref
  2. Berry Anthocyanins and Their Metabolites in Endothelial Dysfunction Associated with Diabetes and Cardiometabolic Risk
    Małgorzata Elżbieta Zujko
    MoleculesPeer-reviewedCC BY 4.0General medicineCrossref
  3. Stress-hyperglycemia ratio, frailty index, and their product in relation to incident cardiometabolic multimorbidity comprising diabetes, heart disease, and stroke: a longitudinal analysis of CHARLS
    Shuheng Liu, Guangbin Xie, Yi Lei +1
    Cardiovascular DiabetologyPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthPMC
  4. Rapid progression of β-cell dysfunction in a patient with glycogen storage disease type 1a complicated by diabetes: longitudinal assessment by serial OGTTs with a review of the literature
    Tetsuro Niri, Ai Haraguchi, Ryoji Sato +7
    Endocrine JournalPeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismJ-STAGE
  5. Associations of cumulative exposure and dynamic trajectories of the combined estimated glucose disposal rate and frailty index with incident cardiometabolic multimorbidity comprising diabetes, heart disease, and stroke: a longitudinal analysis based on the China health and retirement longitudinal study (CHARLS)
    Yi Lei, Junming Li, Wenqiang Xin
    Cardiovascular DiabetologyPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthPMC
BibTeX
@article{yu2026longitudinal,
  title = {{Longitudinal Modeling of Cardiometabolic Dysfunction in Patients With Type 2 Diabetes Using Item Response Theory}},
  author = {Chengli Yu and Hanna Kunina and Gustaf J. Wellhagen and Maria C. Kjellsson},
  journal = {CPT: Pharmacometrics \& Systems Pharmacology},
  year = {2026},
  month = oct,
  doi = {10.1002/psp4.70349},
  url = {https://doi.org/10.1002/psp4.70349},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Longitudinal Modeling of Cardiometabolic Dysfunction in Patients With Type 2 Diabetes Using Item Response Theory
AU  - Chengli Yu
AU  - Hanna Kunina
AU  - Gustaf J. Wellhagen
AU  - Maria C. Kjellsson
PY  - 2026
DA  - 2026/10/15
JO  - CPT: Pharmacometrics & Systems Pharmacology
DO  - 10.1002/psp4.70349
UR  - https://doi.org/10.1002/psp4.70349
AB  - Cardiometabolic dysfunction in patients with type 2 diabetes (T2D) is reflected by multiple risk factors and cannot be fully characterized by any single biomarker. Item response theory (IRT) provides a framework for integrating observed risk factors into latent measures of underlying cardiometabolic dysfunction. Routinely collected measurements of systolic and diastolic blood pressure (sBP and dBP), high‐ and low‐density lipoproteins (HDL and LDL), triglycerides (TG), HbA1c, and BMI from 33,396 adults newly diagnosed with T2D were analyzed, with biomarkers categorized into four ordered levels. A two‐dimensional model described the data better than a unidimensional, identifying a blood pressure‐related latent variable (ψ 1) primarily informed by sBP and dBP, and a metabolic latent variable (ψ 2) primarily informed by HDL, HbA1c, TG, and BMI, while LDL showed low discrimination on both dimensions. At baseline, age at T2D diagnosis was associated with both latent variables, with opposing effects of 0.02 for ψ 1 and −0.07 for ψ 2. Sex was associated with ψ 2, with women scoring 0.43 units lower than men on the latent variable scale. Longitudinally, ψ 1 and ψ  2 showed post‐baseline offsets of −0.10 and −0.22, respectively, followed by separately estimated annual slopes of approximately −0.03 year−1. HbA1c exhibited a distinct trajectory with an initial post‐baseline improvement followed by deterioration, requiring an item‐specific slope of 0.45 year−1. The ψ 2 contributed modest additional information for all‐cause mortality beyond age and sex. This framework integrated routinely collected biomarkers into continuous latent measures of multidimensional cardiometabolic dysfunction while accounting for differences in their contributions to the latent dimensions.
SN  - 2163-8306
ER  -